J. Clin. Med., Volume 7, Issue 8 (August 2018) – 46 articles
Cover Story (view full-size image): Liver cancer is hard to diagnose as symptoms and signs are vague and nonspecific. In addition, hepatocarcinogenesis comprises of multiple, complex steps that occur after liver injury and usually involve several pathways. In this review, we focus on studies in HCC is the research and development of combined therapies involving multi-molecule, multi-channel targeted drug combination therapy strategies. We furnish an overview of recent basic and clinical studies to provide a strong foundation to develop novel anti-carcinogenesis targets for further treatment interventions. Read on to learn more about how technology and drug development are converging to realize the promise of precise targeted therapy. View the paper here.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.